Bringing the "joy of seeing" to the world beyond borders! Launching "domestic and international eye care support activities" for the 10th year with 10 business partners

What is a social partner?

This retail business partner works in conjunction with Rohto Pharmaceutical Co., Ltd. to donate a portion of its sales to social contribution activities, such as medical support in Japan and around the world. For the 10th term, a portion of the sales of "V ROHTO PREMIUM," "V Rohto Contact Premium," "V Rohto Active Premium," "V Rohto Dry Eye Premium," and "Rohto Kodomo Soft" from December 1, 2025 to April 30, 2026 will be donated.

From left to right: "V ROHTO PREMIUM" (Category 2 pharmaceutical): for tired and red eyes; "V Rohto Contact Premium" (Category 3 pharmaceutical): for discomfort while wearing contact lenses; "V Rohto Active Premium" (Category 2 pharmaceutical): for tired eyes and blurred vision due to excessive eye discharge; "V Rohto Dry Eye Premium" (Category 3 pharmaceutical): for dry eyes; "Rohto Kodomo Soft" (Category 3 pharmaceutical): for eye strain in children.

Total amount of donations to date

From the first to the ninth phase, we received support from 38 of our business partners, and the total amount donated is 17,127,360 yen.

Background of the activities

Cataracts are the leading cause of blindness worldwide, and it is estimated that tens of millions of people still lose their sight each year. Cataracts are a disease in which the lens of the eye, which acts as the eye's lens, becomes cloudy, leading to decreased vision. In Japan, advances in surgical techniques have significantly reduced blindness due to cataracts, but in developing countries, poverty, a shortage of doctors and medical equipment, and underdeveloped surgical systems mean that many people still cannot receive treatment. Our company has been working to provide free eye examinations, intraocular lenses, and train local doctors, but our support has not been sufficient. With the desire to bring the "joy of seeing" to more people, we have been collaborating with our business partners as "social partners" to expand the circle of support.
Furthermore, in recent years, childhood myopia has been rapidly increasing in Japan, making the importance of daily eye care awareness even greater. Our company is strengthening awareness activities and product development to protect children's eyes, and in our 10th term, we will add "Rohto Kodomo Soft" to our target product line and work even harder with our social partners to support activities that protect children's eyes.

Donation recipient

In addition to our existing efforts to support organizations and medical institutions in Asia, Africa, and other regions that treat cataracts that can cause blindness, provide technical guidance on cataract surgery, and donate ophthalmic medical equipment and intraocular lens medications, we now plan to donate to organizations that work to protect children's eyes.

Results of the 9th Phase of Support Activities

OUI Inc. (OUI Corporation)

OUI Inc. is a venture company spun off from Keio University School of Medicine, founded by a practicing ophthalmologist. Their mission is to reduce blindness worldwide by 50% and protect people's health through eye care. Based on the concept of spreading the "eyes" of ophthalmologists to the world, they have developed a smartphone-attachable ophthalmic diagnostic device called Smart Eye Camera (SEC). Using the portable and easy-to-use SEC, they are dedicated to delivering ophthalmic care to patients around the world, including those in developing countries, who have previously had difficulty accessing ophthalmic medical care itself.
In the 9th term, opportunities to communicate the value of SEC on an international stage expanded significantly. A joint project with TBWA/HAKUHODO was shortlisted in the Pharma category of "Cannes Lions 2025," providing an opportunity to demonstrate its significance as a medical device to the world. We also participated in ophthalmology conferences in Tanzania, Ethiopia, and Nigeria, exchanging opinions with many doctors, which led to its introduction in Somalia. Furthermore, in Brazil, we visited a screening project for indigenous people, experiencing firsthand the expansion of telemedicine. Through these activities, we are advancing the development of collaborative models with local medical institutions and conducting full-scale pilot programs with the support of international organizations such as the ADB and IDB.

Activities of OUI Inc. (OUI Corporation)

• 

  Panels displayed at the Cannes Lions festival.

• 

  Ophthalmic screening for indigenous people in Brazil

NPO Asia Blindness Prevention Association

The NPO Asia Blindness Prevention Association was founded by a group of volunteers who sympathized with Dr. Tadashi Hattori, a graduate of the Department of Ophthalmology at Kyoto Prefectural University of Medicine. With the desire to prevent even one person from losing their sight in the Indochina Peninsula and other poor countries in Asia, mainly Vietnam, the organization provides free ophthalmic treatment and technical training in those areas.
In fiscal year 2025 (*), we expanded our medical support efforts, primarily in Vietnam and the Philippines, with the aim of preventing blindness. We provided education and training in ophthalmic medical technology at institutions such as the Hanoi Medical University Hospital and the Municipal Eye Hospital. Furthermore, between October 2024 and August 2025, we provided free cataract surgery and technical support to over 700 people, mainly in provincial cities in both countries. The organization's ongoing activities have been highly praised locally, including the awarding of an honorary medal from Ninh Thuan Province in Vietnam. In addition, the year was also dedicated to human resource development, including accepting volunteers from Japanese and local high school students and providing them with opportunities to learn about the field of medical support.

*Fiscal year 2025 = The organization's fiscal year (October 1, 2024 to September 30, 2025)

Activities of the NPO Asia Association for the Prevention of Blindness

• 

  Treatment in Vietnam

• 

  High school students who participated as volunteers

• "V ROHTO PREMIUM" is a registered trademark of ROHTO Pharmaceutical Co., Ltd.
• "V Rohto Active Premium" is a registered trademark of ROHTO Pharmaceutical Co., Ltd.
• "Contact Premium" is a registered trademark of ROHTO Pharmaceutical Co., Ltd.
• "Kodomo Soft" is a registered trademark of ROHTO Pharmaceutical Co., Ltd.

Reference Information: Our company's social contribution activities related to eye health overseas

• Supporting the Amazon Cataract Eradication Project

  This initiative has been providing continuous support for over 20 years to improve the situation of indigenous communities in Brazil who have difficulty accessing ophthalmic care. Our Brazilian eye drop manufacturer and distributor, Ophthalmos S.A., participates as volunteer staff and provides cataract surgery products free of charge, contributing to healthcare that transcends regional and ethnic barriers.

• PT. Rohto Laboratories Indonesia 's support for free cataract surgeries

  PT. Rohto Laboratories Indonesia in the ASEAN region to manufacture and sell intraocular lenses for cataract surgery. For many years, the company has been engaged in social contribution activities, including providing intraocular lenses free of charge, in close cooperation with various stakeholders such as hospitals, ophthalmology clinics, and foundations. These activities extend beyond Indonesia to neighboring countries, including Thailand and Myanmar, contributing to the overall "eye health" of the region.

• Bringing the joy of seeing to the world, beyond national borders! The "Joy of Seeing Project"

  In collaboration with Rohto Group companies overseas, we are continuously developing the "Joy of Seeing (JoS)" project both domestically and internationally to protect people's eye health worldwide. In 2024, in addition to addressing "children's eye health and myopia," we expanded our activities to 10 countries and regions, mainly in Asia, including Japan, to address issues such as cataracts and dry eye. We have collaborated with local stakeholders to carry out social contribution activities such as awareness events (with a total of approximately 108,000 participants), free eye examinations (for approximately 77,900 people), information dissemination, and the free provision of eyeglasses and other related items. Through these efforts, we are contributing to the realization of a sustainable society and the improvement of the health of local communities.

Details of the initiative, 2024 activity report